Stage III Anal Cancer AJCC v8

general

Stage IIIB includes: T4, N0, M0. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)

66

Centers

99

Active Trials

Cancer Funding

Top Centers for Stage III Anal Cancer AJCC v8(66)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.2
2
High-Volume Research Center
72.2
3
High-Volume Research Center
72.2
4
NCI Comprehensive
Active Research Program
62.0
5
NCI Comprehensive
Active Research Program
62.0
6
NCI Comprehensive
Active Research Program
62.0
7
NCI Comprehensive
Active Research Program
62.0
8
NCI Comprehensive
Active Research Program
62.0
9
NCI Comprehensive
Active Research Program
62.0
10
NCI Comprehensive
Active Research Program
62.0
1162.0
12
NCI Comprehensive
Active Research Program
62.0
13
NCI Comprehensive
Active Research Program
62.0
14
NCI Comprehensive
Active Research Program
62.0
15
NCI Comprehensive
Active Research Program
62.0
16
NCI Clinical
Active Research Program
62.0
17
NCI Comprehensive
Active Research Program
62.0
18
Active Research Program
62.0
19
NCI Comprehensive
Active Research Program
62.0
20
Active Research Program
62.0
21
Active Research Program
62.0
22
NCI Clinical
Active Research Program
62.0
23
NCI Comprehensive
Active Research Program
62.0
24
NCI Clinical
Active Research Program
62.0
25
Active Research Program
62.0
26
NCI Comprehensive
Active Research Program
62.0
2762.0
28
Active Research Program
62.0
29
Active Research Program
62.0
30
Active Research Program
62.0
31
NCI Comprehensive
Active Research Program
40.5
32
NCI Comprehensive
Active Research Program
40.5
33
NCI Comprehensive
Active Research Program
40.5
34
NCI Comprehensive
Active Research Program
40.5
35
NCI Comprehensive
Active Research Program
40.5
36
NCI Comprehensive
Active Research Program
40.5
37
NCI Comprehensive
Active Research Program
40.5
38
NCI Comprehensive
Active Research Program
40.5
39
NCI Comprehensive
Active Research Program
40.5
40
NCI Comprehensive
Active Research Program
40.5
41
NCI Comprehensive
Active Research Program
40.5
42
NCI Comprehensive
Active Research Program
40.5
43
NCI Comprehensive
Active Research Program
40.5
44
NCI Comprehensive
Active Research Program
40.5
45
NCI Clinical
Active Research Program
40.5
46
NCI Comprehensive
Active Research Program
40.5
47
NCI Comprehensive
Active Research Program
40.5
48
NCI Comprehensive
Active Research Program
40.5
49
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
40.5
50
NCI Comprehensive
Active Research Program
40.5
51
NCI Comprehensive
Active Research Program
40.5
52
NCI Comprehensive
Active Research Program
40.5
53
NCI Comprehensive
Active Research Program
40.5
54
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
40.5
55
NCI Comprehensive
Active Research Program
40.5
56
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
40.5
57
Active Research Program
40.5
58
NCI Basic_laboratory
Active Research Program
40.5
59
Active Research Program
40.5
60
Active Research Program
40.5
61
Active Research Program
40.5
62
Active Research Program
40.5
63
Active Research Program
40.5
64
BC CancerVancouver, BC
Active Research Program
40.5
65
Active Research Program
40.5
66
Active Research Program
40.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →